Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma
Phase III Placebo-Controlled Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma Patients
Sponsor: Buddhist Tzu Chi General Hospital
This PHASE3 trial investigates Oral Cavity and Squamous Cell Carcinoma and is currently completed. Buddhist Tzu Chi General Hospital leads this study, which shows 6 recorded versions since 1999 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Oct 2017 — Jan 2021 [monthly]
Completed PHASE3
-
Sep 2017 — Oct 2017 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Sep 2017 [monthly]
Completed PHASE3
First recorded
Apr 1999
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Buddhist Tzu Chi General Hospital
- Chang Gung Memorial Hospital
- Changhua Christian Hospital
- Chi Mei Medical Hospital
- China Medical University Hospital
- Koo Foundation Sun Yat-Sen Cancer Center
- Mackay Memorial Hospital
- National Cheng-Kung University Hospital
- National Health Research Institutes, Taiwan
- National Taiwan University Hospital
- Taichung Veterans General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .